论文信息 - Molecular target therapy for bone metastasis: starting a new era with denosumab, a RANKL inhibitor - 字舞流文

Molecular target therapy for bone metastasis: starting a new era with denosumab, a RANKL inhibitor

A. Russo | N. Reguart | G. Bronte | C. Rolfo | L. Raez | F. Silvestris | R. Campelo | K. Papadimitriou